VEGFA and Alzheimer disease: Likewise, the AD GAGs decreased VEGF binding and capacity to potentiate activity is in accord with the previously observed loss of VEGF capacity to promote brain angiogenesis, neuroprotection and cerebro-microvascular permeability in AD [40, 41].